铁死亡的发生机制及在肝脏疾病中的作用

张飞宇; 阿迪拉·亚克普; 赵金明; 高沿航

doi:10.3969/j.issn.1001-5256.2021.06.049

铁死亡的发生机制及在肝脏疾病中的作用

DOI: 10.3969/j.issn.1001-5256.2021.06.049

吉林大学第一医院肝病科，长春 130021

基金项目:

国家自然科学基金 (81972265);

国家重点研发计划“精准医学研究”专项 (2017YFC0908103);

“艾滋病和病毒性肝炎等重大传染病防治”国家科技重大专项 (2017ZX10202202);

“艾滋病和病毒性肝炎等重大传染病防治”国家科技重大专项 (2018ZX10302206);

吉林省自然科学基金 (20200201324JC)

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：张飞宇负责选题，收集分析资料，撰写文章；阿迪拉·亚克普、赵金明参与选题，收集资料；高沿航教授拟定写作思路，指导撰写文章，提供修改意见并最终定稿。

详细信息

作者简介:
张飞宇(1995—)，男，主要从事肝胆胰腺疾病研究

通信作者:
高沿航，yanhang@mail.jlu.edu.cn

中图分类号: R575
计量
- 文章访问数: 1501
- HTML全文浏览量: 606
- PDF下载量: 184
- 被引次数: 0
出版历程
- 收稿日期: 2020-11-30
- 录用日期: 2020-12-29
- 出版日期: 2021-06-20

Mechanism of ferroptosis and its role in liver diseases

Department of Hepatology, The First Hospital of Jilin University, Changchun 130021, China

摘要

摘要: 铁死亡是新近发现的一种铁依赖性、脂质过氧化物集聚导致的调节性细胞死亡，其形态学特征为线粒体体积缩小、膜密度增加和线粒体减少或消失。发生机制主要与铁代谢紊乱、氨基酸抗氧化系统失衡、脂质过氧化物集聚有关。研究显示，铁死亡在不同的肝脏疾病背景下扮演不同角色，铁死亡的发生可参与多种肝脏炎症疾病进展，也可抑制肝纤维化形成、肝癌发生及索拉非尼耐药。总结了铁死亡发生机制及其在肝脏疾病中的作用和进展，旨在为肝脏疾病的进一步研究与治疗提供参考。
- 肝疾病 /
- 铁死亡 /
- 细胞死亡 /
- 铁代谢
Abstract: Ferroptosis is a newly discovered regulatory cell death induced by the accumulation of iron-dependent lipid peroxides, with the morphological manifestations of decreased mitochondrial volume, increased mitochondrial membrane density, and reduction or disappearance of mitochondria. The mechanism of ferroptosis is mainly associated with disturbance of iron metabolism, imbalance of amino acid antioxidant system, and accumulation of lipid peroxides. Studies have shown that ferroptosis plays different roles in different liver diseases, and ferroptosis can participate in the progression of various liver inflammatory diseases and inhibit the formation of liver fibrosis, the development of hepatocellular carcinoma, and sorafenib resistance. This article summarizes the advances in the mechanism of ferroptosis and its role in liver diseases, so as to provide a reference for further research and treatment of liver diseases.
- Liver Diseases /
- Ferroptosis /
- Cell Death /
- Iron Metabolism

HTML全文

图 1 4种细胞死亡方式机制图

注：a, 肝细胞的外源性凋亡机制; b, 坏死性凋亡机制; c, 焦亡机制; d, 自噬机制。

下载: 全尺寸图片幻灯片

图 2 铁死亡发生机制图

下载: 全尺寸图片幻灯片

参考文献(40)

[1]	DIXON SJ, LEMBERG KM, LAMPRECHT MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072. DOI: 10.1016/j.cell.2012.03.042.
[2]	ZHOU Z, YE TJ, DECARO E, et al. Intestinal SIRT1 deficiency protects mice from ethanol-induced liver injury by mitigating ferroptosis[J]. Am J Pathol, 2020, 190(1): 82-92. DOI: 10.1016/j.ajpath.2019.09.012.
[3]	LI X, WANG TX, HUANG X, et al. Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity[J]. Liver Int, 2020, 40(6): 1378-1394. DOI: 10.1111/liv.14428.
[4]	LÖRINCZ T, JEMNITZ K, KARDON T, et al. Ferroptosis is involved in acetaminophen induced cell death[J]. Pathol Oncol Res, 2015, 21(4): 1115-1121. DOI: 10.1007/s12253-015-9946-3.
[5]	LOUANDRE C, EZZOUKHRY Z, GODIN C, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib[J]. Int J Cancer, 2013, 133(7): 1732-1742. DOI: 10.1002/ijc.28159.
[6]	YANG WS, STOCKWELL BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]. Chem Biol, 2008, 15(3): 234-245. DOI: 10.1016/j.chembiol.2008.02.010.
[7]	DOLMA S, LESSNICK SL, HAHN WC, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell, 2003, 3(3): 285-296. DOI: 10.1016/s1535-6108(03)00050-3.
[8]	YANG WS, SRIRAMARATNAM R, WELSCH ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331. DOI: 10.1016/j.cell.2013.12.010.
[9]	JIANG L, KON N, LI T, et al. Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015, 520(7545): 57-62. DOI: 10.1038/nature14344.
[10]	SATO M, KUSUMI R, HAMASHIMA S, et al. The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells[J]. Sci Rep, 2018, 8(1): 968. DOI: 10.1038/s41598-018-19213-4.
[11]	MANCIAS JD, WANG X, GYGI SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy[J]. Nature, 2014, 509(7498): 105-109. DOI: 10.1038/nature13148.
[12]	KAGAN VE, MAO G, QU F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis[J]. Nat Chem Biol, 2017, 13(1): 81-90. DOI: 10.1038/nchembio.2238.
[13]	BRUNI A, PEPPER AR, PAWLICK RL, et al. Ferroptosis-inducing agents compromise in vitro human islet viability and function[J]. Cell Death Dis, 2018, 9(6): 595. DOI: 10.1038/s41419-018-0506-0.
[14]	SUN X, OU Z, CHEN R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells[J]. Hepatology, 2016, 63(1): 173-184. DOI: 10.1002/hep.28251.
[15]	SUN X, OU Z, XIE M, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death[J]. Oncogene, 2015, 34(45): 5617-5625. DOI: 10.1038/onc.2015.32.
[16]	DOLL S, PRONETH B, TYURINA YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1): 91-98. DOI: 10.1038/nchembio.2239.
[17]	DIXON SJ, WINTER GE, MUSAVI LS, et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death[J]. ACS Chem Biol, 2015, 10(7): 1604-1609. DOI: 10.1021/acschembio.5b00245.
[18]	SHINTOKU R, TAKIGAWA Y, YAMADA K, et al. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3[J]. Cancer Sci, 2017, 108(11): 2187-2194. DOI: 10.1111/cas.13380.
[19]	WANG H, AN P, XIE E, et al. Characterization of ferroptosis in murine models of hemochromatosis[J]. Hepatology, 2017, 66(2): 449-465. DOI: 10.1002/hep.29117.
[20]	DOSTALIKOVA-CIMBUROVA M, BALUSIKOVA K, KRATKA K, et al. Role of duodenal iron transporters and hepcidin in patients with alcoholic liver disease[J]. J Cell Mol Med, 2014, 18(9): 1840-1850. DOI: 10.1111/jcmm.12310.
[21]	YIN H, HU M, LIANG X, et al. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver[J]. Gastroenterology, 2014, 146(3): 801-811. DOI: 10.1053/j.gastro.2013.11.008.
[22]	ESLAM M, NEWSOME PN, SARIN SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209. DOI: 10.1016/j.jhep.2020.03.039.
[23]	TSURUSAKI S, TSUCHIYA Y, KOUMURA T, et al. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis[J]. Cell Death Dis, 2019, 10(6): 449. DOI: 10.1038/s41419-019-1678-y.
[24]	ZHANG Z, YAO Z, WANG L, et al. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells[J]. Autophagy, 2018, 14(12): 2083-2103. DOI: 10.1080/15548627.2018.1503146.
[25]	SUI M, JIANG X, CHEN J, et al. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway[J]. Biomed Pharmacother, 2018, 106: 125-133. DOI: 10.1016/j.biopha.2018.06.060.
[26]	ZHANG X, SUI S, WANG L, et al. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin[J]. J Cell Physiol, 2020, 235(4): 3425-3437. DOI: 10.1002/jcp.29232.
[27]	TANG H, CHEN D, LI C, et al. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells[J]. Int J Pharm, 2019, 572: 118782. DOI: 10.1016/j.ijpharm.2019.118782.
[28]	OU Y, WANG SJ, LI D, et al. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses[J]. Proc Natl Acad Sci U S A, 2016, 113(44): e6806-e6812. DOI: 10.1073/pnas.1607152113.
[29]	GAO M, MONIAN P, QUADRI N, et al. Glutaminolysis and transferrin regulate ferroptosis[J]. Mol Cell, 2015, 59(2): 298-308. DOI: 10.1016/j.molcel.2015.06.011.
[30]	YUAN H, LI X, ZHANG X, et al. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation[J]. Biochem Biophys Res Commun, 2016, 478(2): 838-844. DOI: 10.1016/j.bbrc.2016.08.034.
[31]	BAI T, LIANG R, ZHU R, et al. MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells[J]. J Cell Physiol, 2020, 235(7-8): 5637-5648. DOI: 10.1002/jcp.29496.
[32]	ZHANG Y, SHI J, LIU X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression[J]. Nat Cell Biol, 2018, 20(10): 1181-1192. DOI: 10.1038/s41556-018-0178-0.
[33]	ZHANG X, DU L, QIAO Y, et al. Ferroptosis is governed by differential regulation of transcription in liver cancer[J]. Redox Biol, 2019, 24: 101211. DOI: 10.1016/j.redox.2019.101211.
[34]	SUN X, NIU X, CHEN R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis[J]. Hepatology, 2016, 64(2): 488-500. DOI: 10.1002/hep.28574.
[35]	BAI T, LEI P, ZHOU H, et al. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells[J]. J Cell Mol Med, 2019, 23(11): 7349-7359. DOI: 10.1111/jcmm.14594.
[36]	BAI T, WANG S, ZHAO Y, et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells[J]. Biochem Biophys Res Commun, 2017, 491(4): 919-925. DOI: 10.1016/j.bbrc.2017.07.136.
[37]	SAUZAY C, LOUANDRE C, BODEAU S, et al. Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells[J]. Oncotarget, 2018, 9(9): 8400-8414. DOI: 10.18632/oncotarget.23843.
[38]	LOUANDRE C, MARCQ I, BOUHLAL H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells[J]. Cancer Lett, 2015, 356(2 Pt B): 971-977. DOI: 10.1016/j.canlet.2014.11.014.
[39]	DENG G, LI Y, MA S, et al. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress[J]. Free Radic Biol Med, 2020, 148: 151-161. DOI: 10.1016/j.freeradbiomed.2019.12.026.
[40]	KAIN HS, GLENNON E, VIJAYAN K, et al. Liver stage malaria infection is controlled by host regulators of lipid peroxidation[J]. Cell Death Differ, 2020, 27(1): 44-54. DOI: 10.1038/s41418-019-0338-1.